febuxostat has been researched along with transforming growth factor beta in 4 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, K; Isaka, Y; Kaimori, J; Kawada, N; Matsui, I; Moriyama, T; Omori, H; Rakugi, H; Takabatake, Y; Ueda, Y; Yamamoto, R | 1 |
| Fan, CX; Li, L; Liang, YL; Lin, ZM; Liu, XN; Qu, JC; Xu, X; Zhang, RS; Zhao, HY; Zhao, L; Zhu, KS | 1 |
| Abdel-Aziz, AM; Ali, AI; Gamal El-Tahawy, NF; Ibrahim, YF; Mohammed, MM; Salah Abdel Haleem, MA | 1 |
| Abdel-Wahab, BA; El-Shoura, EAM; Shafiuddin Habeeb, M; Zafaar, D | 1 |
4 other study(ies) available for febuxostat and transforming growth factor beta
| Article | Year |
|---|---|
Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy.
Topics: Animals; Cell Movement; Cytokines; Disease Models, Animal; Febuxostat; Fibrosis; Kidney; Kidney Diseases; Macrophages; Male; Nephritis, Interstitial; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thiazoles; Transforming Growth Factor beta; Ureteral Obstruction; Xanthine Oxidase | 2012 |
[Effect of febuxostat on epithelial-to-mesenchymal transition of kidney tubules, serum interleukin-6 and transforming growth factor β(1) in hyperuricemic rats].
Topics: Animals; Antigens, CD; Cadherins; Chalcone; Creatinine; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Febuxostat; Gout Suppressants; Hyperuricemia; Interleukin-6; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1; Uric Acid | 2017 |
Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Febuxostat; Male; Nitric Oxide Synthase Type II; Prostatic Hyperplasia; Rats; Rats, Wistar; Testosterone Propionate; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2020 |
Febuxostat alleviates Arsenic Trioxide-Induced renal injury in Rats: Insights on the crosstalk between NLRP3/TLR4, Sirt-1/NF-κB/TGF-β signaling Pathways, and miR-23b-3p, miR-181a-5b expression.
Topics: Animals; Arsenic Trioxide; Febuxostat; Kidney; Kidney Diseases; MicroRNAs; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Signal Transduction; Toll-Like Receptor 4; Transforming Growth Factor beta | 2023 |